Category

Leadership

← All posts
Executive

Psychedelic Guide Credentials: The Vetting Questions That Matter

Psychedelic guide credentials are not standardized across the field, which means the quality of support you receive depends heavily on who you choose and how carefully...

May 31, 2026 · 9 min
Executive

Psychedelic Therapy Screening: Are You a Candidate?

A psychedelic therapy screening assessment is the structured clinical process that determines whether you are a suitable candidate for psilocybin or similar modalities. For high-performing individuals,...

May 27, 2026 · 8 min
Executive

Psychedelic Therapy FAQ: Honest Answers for the Educated Seeker

This psychedelic therapy FAQ compiles the most common and most important questions from people seriously considering psilocybin or other psychedelic-assisted approaches. The answers here are grounded...

May 26, 2026 · 10 min
Executive

The JOM11 Framework: Concierge Psychedelic Therapy for Executives

The JOM11 psychedelic executive program is JourneyOM’s structured, concierge-level pathway for senior leaders who want to address burnout, cognitive rigidity, or performance plateaus through professionally supported...

May 23, 2026 · 9 min
Executive

How Much Does Psychedelic Therapy Cost and Why Cheap Is Risky

How much does psychedelic therapy cost? Depending on the modality, setting, and level of support, a full course of professionally supported treatment in the United States...

May 5, 2026 · 9 min
Executive

Executive Burnout Psychedelic Therapy: What the Research Shows

Executive burnout psychedelic therapy is moving from the research margins into serious clinical conversation. A growing body of peer-reviewed evidence suggests that psilocybin-assisted therapy can reduce...

April 26, 2026 · 8 min
Executive

Psychedelics and Creativity: What Executives Need to Know

Interest in psychedelics and creativity among executives has moved well beyond Silicon Valley. Neuroscientific research points to measurable changes in divergent thinking, cognitive flexibility, and problem-solving...

April 22, 2026 · 9 min
Harm Reduction

Psychedelic Therapy Privacy: What Executives Need to Know

Psychedelic therapy privacy is one of the most legitimate concerns executives and public figures raise before pursuing treatment. HIPAA protections apply to licensed clinical providers, and...

April 19, 2026 · 9 min
Conditions

Set and Setting in 2026: A Psychedelic Preparation Guide for High-Performers

Set and setting psychedelics research refers to the two core non-pharmacological factors that shape a psilocybin experience: your internal state (set) and the physical and relational...

April 17, 2026 · 9 min
Conditions

What executives are actually using psychedelic therapy for (and what the data shows)

Psychedelic therapy for executives is moving beyond reputation and into clinical evidence. A growing number of C-suite leaders are using professionally supported psilocybin and ketamine experiences...

April 15, 2026 · 8 min

Ready to take the next step?

Start with a complimentary conversation, or take the two-minute self-evaluation to see if this is your moment.